The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated a
worldwide emergency, until the declaration of the pandemic in March 2020. SARS-CoV-2 …

Coronavirus disease 2019 (COVID-19) vaccines proved a strong clinical efficacy against
symptomatic or moderate/severe COVID-19 and are considered the most promising …

SARS-CoV-2, a novel coronavirus found in Wuhan (China) at the end of 2019, is the
etiological agent of the current pandemic that is a heterogeneous disease, named …

Cardiovascular diseases (CVDs) are the main contributors to global morbidity and mortality.
Major pathogenic phenotypes of CVDs include the development of endothelial dysfunction …

Purpose To investigate the clinical predictors of in-hospital mortality in hospitalized patients
with Coronavirus disease 2019 (COVID-19) infection during the Omicron period. Methods All …

Among the various comorbidities potentially worsening the clinical outcome in patients
hospitalized for the acute respiratory syndrome coronavirus-2 (SARS-CoV-2), hypertension …

The role of a dysregulated renin-angiotensin system (RAS) in the pathogenesis of COVID-19
is well recognized. The imbalance between angiotensin II (Ang II) and Angiotensin 1-7 (Ang …

It was shown that hypertension delays SARS CoV-2 viral clearance and exacerbates airway
hyperinflammation in the respiratory tract. However, it is unknown whether hypertension …

Abstract Continued receipt of Renin–Angiotensin–Aldosterone inhibitors in patients with
COVID-19 has shown potential in producing better clinical outcomes. However, superiority …

After assessing the levels of spread and severity of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, academic literature focused on the pathophysiology …